Screening history of women in Malmö with invasive cervical cancer.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Standard

Screening history of women in Malmö with invasive cervical cancer. / Lindqvist, Pelle; Hellsten, Charlotte; Rippe, Amanda.

I: European Journal of Obstetrics, Gynecology, and Reproductive Biology, Vol. 137, Nr. 1, 2008, s. 77-83.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Harvard

APA

CBE

MLA

Vancouver

Author

Lindqvist, Pelle ; Hellsten, Charlotte ; Rippe, Amanda. / Screening history of women in Malmö with invasive cervical cancer. I: European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2008 ; Vol. 137, Nr. 1. s. 77-83.

RIS

TY - JOUR

T1 - Screening history of women in Malmö with invasive cervical cancer.

AU - Lindqvist, Pelle

AU - Hellsten, Charlotte

AU - Rippe, Amanda

N1 - The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pediatrics/Urology/Gynecology/Endocrinology (013240400)

PY - 2008

Y1 - 2008

N2 - Objectives Cervical cancer is one of the most common forms of cancer among women. Cytological screening and follow-up are potentially effective procedures for preventing the development of – and mortality from – cervical cancer. The purpose of this study was to investigate the screening history of women diagnosed with cervical cancer with the aim of improving the screening programme. Study design All of the 187 women diagnosed with invasive cervical cancer in Malmö between 1991 and 2000 were identified, and those below 61 years of age (n = 130) were included in the analysis. The cytological and histological screening history of these women prior to their diagnosis was scrutinized. We analyzed shortcomings related to the cervical screening with special attention to participation defined as having had a cervical smear within 1 year of the scheduled time. Results Of the non-participants who developed cervical cancer (n = 70), roughly one-third “never participated,” half were “sub-optimal participants,” and one-sixth were “decliners,” i.e., women who declined the recommended measures. Among participants (n = 60), 80% were either “unexplained” (n = 35) or “misread as normal” (n = 13). The 9.5% subgroup of non-participants was at an 11-fold increased risk of being diagnosed with invasive cervical cancer. Conclusion The greatest reduction in cervical cancer would be realized if non-participants could be brought into the screening program.

AB - Objectives Cervical cancer is one of the most common forms of cancer among women. Cytological screening and follow-up are potentially effective procedures for preventing the development of – and mortality from – cervical cancer. The purpose of this study was to investigate the screening history of women diagnosed with cervical cancer with the aim of improving the screening programme. Study design All of the 187 women diagnosed with invasive cervical cancer in Malmö between 1991 and 2000 were identified, and those below 61 years of age (n = 130) were included in the analysis. The cytological and histological screening history of these women prior to their diagnosis was scrutinized. We analyzed shortcomings related to the cervical screening with special attention to participation defined as having had a cervical smear within 1 year of the scheduled time. Results Of the non-participants who developed cervical cancer (n = 70), roughly one-third “never participated,” half were “sub-optimal participants,” and one-sixth were “decliners,” i.e., women who declined the recommended measures. Among participants (n = 60), 80% were either “unexplained” (n = 35) or “misread as normal” (n = 13). The 9.5% subgroup of non-participants was at an 11-fold increased risk of being diagnosed with invasive cervical cancer. Conclusion The greatest reduction in cervical cancer would be realized if non-participants could be brought into the screening program.

U2 - 10.1016/j.ejogrb.2006.12.005

DO - 10.1016/j.ejogrb.2006.12.005

M3 - Article

C2 - 17210219

VL - 137

SP - 77

EP - 83

JO - European Journal of Obstetrics, Gynecology, and Reproductive Biology

JF - European Journal of Obstetrics, Gynecology, and Reproductive Biology

SN - 0301-2115

IS - 1

ER -